Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG Bubendorf CH
02 2ASPEN OSS B.V. Oss NL
03 1TEVA PHARMACEUTICAL INDUSTRIES LTD Petach Tikva IL
04 2BCN PEPTIDES S.A. St Quinti De Mediona ES
05 1CHEMI S.P.A. Patrica IT
06 1HYBIO PHARMACEUTICAL CO., LTD. Shenzhen CN
07 1MALLINCKRODT, INC. Hazelwood US
08 1PIRAMAL PHARMA LIMITED Navi Mumbai IN
09 1PolyPeptide Laboratories (Sweden) AB Limhamn SE
10 1PolyPeptide Laboratories Inc. Torrance US
11 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
12 1Takeda Pharmaceutical Company, Limited Osaka JP
13 1ZHEJIANG PEPTITES BIOTECH CO., LTD. Sanjie Town CN
01 12Leuprorelin
02 1Leuprorelin, NR
03 1Leuprorelin, Process F
04 1Leuprorelin, sterile
01 2China
02 1India
03 1Israel
04 1Italy
05 1Japan
06 2Netherlands
07 2Spain
08 2Switzerland
09 3U.S.A
01 13Valid
02 2Withdrawn by Holder
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Certificate Number : R1-CEP 2001-454 - Rev 01
Status : Valid
Issue Date : 2009-02-18
Type : Chemical
Substance Number : 1442
Certificate Number : R1-CEP 2016-199 - Rev 00
Status : Valid
Issue Date : 2022-08-26
Type : Chemical
Substance Number : 1442
Certificate Number : R1-CEP 2006-028 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2015-07-15
Type : Chemical
Substance Number : 1442
Certificate Number : R0-CEP 2021-472 - Rev 00
Status : Valid
Issue Date : 2022-02-28
Type : Chemical
Substance Number : 1442
Certificate Number : R1-CEP 2008-115 - Rev 04
Status : Valid
Issue Date : 2022-03-10
Type : Chemical
Substance Number : 1442
Certificate Number : CEP 2011-274 - Rev 02
Status : Valid
Issue Date : 2024-03-04
Type : Chemical
Substance Number : 1442
Certificate Number : R1-CEP 2003-045 - Rev 00
Status : Valid
Issue Date : 2009-02-13
Type : Chemical
Substance Number : 1442
Certificate Number : R1-CEP 2011-321 - Rev 02
Status : Valid
Issue Date : 2023-01-26
Type : Chemical
Substance Number : 1442
Certificate Number : R1-CEP 2001-441 - Rev 03
Status : Valid
Issue Date : 2022-07-29
Type : Chemical
Substance Number : 1442
Certificate Number : R0-CEP 2020-305 - Rev 00
Status : Valid
Issue Date : 2022-03-04
Type : Chemical
Substance Number : 1442
A Leuprolide Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leuprolide Acetate, including repackagers and relabelers. The FDA regulates Leuprolide Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leuprolide Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Leuprolide Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Leuprolide Acetate supplier is an individual or a company that provides Leuprolide Acetate active pharmaceutical ingredient (API) or Leuprolide Acetate finished formulations upon request. The Leuprolide Acetate suppliers may include Leuprolide Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Leuprolide Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Leuprolide Acetate CEP of the European Pharmacopoeia monograph is often referred to as a Leuprolide Acetate Certificate of Suitability (COS). The purpose of a Leuprolide Acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Leuprolide Acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Leuprolide Acetate to their clients by showing that a Leuprolide Acetate CEP has been issued for it. The manufacturer submits a Leuprolide Acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Leuprolide Acetate CEP holder for the record. Additionally, the data presented in the Leuprolide Acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Leuprolide Acetate DMF.
A Leuprolide Acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Leuprolide Acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Leuprolide Acetate suppliers with CEP (COS) on PharmaCompass.
We have 12 companies offering Leuprolide Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?